Team: Bios

Ashley Dombkowski, PhD Managing Director

Dr. Ashley Dombkowski joined MPM Capital in 2000. Before joining MPM, she was a public market investor and Healthcare Equity Analyst covering biotech, medical device, and pharmaceutical stocks for Tiger Management, L.L.C., a diversified hedge fund. Prior to Tiger, Dr. Dombkowski followed the all-cap universe of public medical technology stocks as an Equity Research Associate at Dresdner RCM Global Investors. Her national media appearances have included outlets such as CNBC and she was recognized as one of the Most Influential Women of 2010 by the San Jose/Silicon Valley Business Journal. Dr. Dombkowski holds a Ph.D. in Mathematics from Rice University and a B.A. cum laude and with Departmental Honors from Wellesley College.

Present Boards
Alnara Pharmaceuticals
EpiZyme, Inc.
Nevro, Inc. (Observer)
iPierian, Inc.

Past Boards
BioVitrum AB (Stockholm:BVT.ST)
Enteromedics, Inc. (NASDAQ:ETRM)
Hemosense, Inc. (Purchased by Inverness Medical Innovations)
LXN Corporation (Purchased by Inverness Medical Innovations)
Neosil, Inc. (Purchased by Peplin)
Peptimmune, Inc.
Portola Pharmaceuticals, Inc.
Restore Medical, Inc. (Purchased by Medtronic)
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)
Tercica, Inc. (Purchased by Ipsen)